Mengyuan Fu

Project Title: Global Impact of FDA Drug Approval, Major Postmarket Labeling Change, and Withdrawal Determinations.

Dr. Fu is a postdoctoral fellow in the Yale School of Medicine. She obtained her PhD from the School of Pharmaceutical Sciences at Peking University, where her research focused on evaluating equitable access to and the appropriate use of medicines in primary care. As a visiting scholar at Harvard Medical School, she expanded her expertise by investigating evidence-based approval processes and market access for novel cancer drugs in the United States. Her CERSI Scholar project seeks to explore the global impact of FDA regulatory decisions.